225 related articles for article (PubMed ID: 22177033)
1. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.
Kang M; Choi S; Jeong SJ; Lee SA; Kwak TK; Kim H; Jung O; Lee MS; Ko Y; Ryu J; Choi YJ; Jeong D; Lee HJ; Ye SK; Kim SH; Lee JW
Biochem J; 2012 May; 443(3):691-700. PubMed ID: 22292774
[TBL] [Abstract][Full Text] [Related]
3. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
[TBL] [Abstract][Full Text] [Related]
4. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β1 induced epithelial-mesenchymal transition in hepatic fibrosis.
Bi WR; Yang CQ; Shi Q
Hepatogastroenterology; 2012 Sep; 59(118):1960-3. PubMed ID: 22369740
[TBL] [Abstract][Full Text] [Related]
6. TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes.
Ryu J; Lee JW
Mediators Inflamm; 2017; 2017():5108525. PubMed ID: 28458469
[TBL] [Abstract][Full Text] [Related]
7. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW
PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
9. Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats.
Lam HB; Yeh CH; Cheng KC; Hsu CT; Cheng JT
Neurosci Lett; 2008 Jun; 438(1):90-5. PubMed ID: 18472332
[TBL] [Abstract][Full Text] [Related]
10. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
Perugorria MJ; Latasa MU; Nicou A; Cartagena-Lirola H; Castillo J; Goñi S; Vespasiani-Gentilucci U; Zagami MG; Lotersztajn S; Prieto J; Berasain C; Avila MA
Hepatology; 2008 Oct; 48(4):1251-61. PubMed ID: 18634036
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
14. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo.
Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP
Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857
[TBL] [Abstract][Full Text] [Related]
15. Apamin inhibits hepatic fibrosis through suppression of transforming growth factor β1-induced hepatocyte epithelial-mesenchymal transition.
Lee WR; Kim KH; An HJ; Kim JY; Lee SJ; Han SM; Pak SC; Park KK
Biochem Biophys Res Commun; 2014 Jul; 450(1):195-201. PubMed ID: 24878534
[TBL] [Abstract][Full Text] [Related]
16. Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes.
Shrestha N; Chand L; Han MK; Lee SO; Kim CY; Jeong YJ
Food Chem Toxicol; 2016 Jul; 93():129-37. PubMed ID: 27137983
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.
Hagiwara S; Otsuka T; Yamazaki Y; Kosone T; Sohara N; Ichikawa T; Sato K; Kakizaki S; Takagi H; Mori M
Liver Int; 2008 Jan; 28(1):126-31. PubMed ID: 17976157
[TBL] [Abstract][Full Text] [Related]
19. Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-beta1.
Doh KO; Jung HK; Moon IJ; Kang HG; Park JH; Park JG
Int J Mol Med; 2008 Jan; 21(1):33-9. PubMed ID: 18097613
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
Kaimori A; Potter JJ; Choti M; Ding Z; Mezey E; Koteish AA
Hepatology; 2010 Sep; 52(3):1033-45. PubMed ID: 20564330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
